Jointown Pharmaceutical Group Co Ltd
SSE:600998

Watchlist Manager
Jointown Pharmaceutical Group Co Ltd Logo
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Watchlist
Price: 4.82 CNY -0.21% Market Closed
Market Cap: 24.3B CNY
Have any thoughts about
Jointown Pharmaceutical Group Co Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one Jointown Pharmaceutical Group Co Ltd stock under the Base Case scenario is 24.3 CNY. Compared to the current market price of 4.82 CNY, Jointown Pharmaceutical Group Co Ltd is Undervalued by 80%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
24.3 CNY
Undervaluation 80%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.2
P/S
P/S
Price to Sales
0.2
vs History
52
vs Industry
90
Median 3Y
0.2
Median 5Y
0.2
Industry
2.3
Forward
0.2
More Details
11.7
P/E
P/E
Price to Earnings
11.7
vs History
31
vs Industry
40
Median 3Y
13
Median 5Y
10.6
Industry
22.8
Forward
10.3
More Details
18.8
P/OCF
P/OCF
Price to OCF
18.8
vs History
7
vs Industry
45
Median 3Y
8.2
Median 5Y
6.3
Industry
14.2
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
35
Median 3Y
8.9
Median 5Y
7
Industry
20.1
More Details
1
P/B
P/B
Price to Book Value
1
vs History
38
vs Industry
64
Median 3Y
1.1
Median 5Y
1
Industry
2.2
More Details
0.4
EV/S
EV/S
Enterprise Value to Sales
0.4
vs History
31
vs Industry
83
Median 3Y
0.4
Median 5Y
0.4
Industry
2.4
Forward
0.4
More Details
5
EV/GP
EV/GP
Enterprise Value to Gross Profit
5
vs History
28
vs Industry
47
Median 3Y
5.2
Median 5Y
4.4
Industry
5
More Details
14.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
14.2
vs History
28
vs Industry
28
Median 3Y
14.7
Median 5Y
12.2
Industry
12.7
Forward
10.9
More Details
14.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
14.2
vs History
28
vs Industry
34
Median 3Y
14.7
Median 5Y
12.2
Industry
17.1
Forward
12.3
More Details
44.3
EV/OCF
EV/OCF
Enterprise Value to OCF
44.3
vs History
7
vs Industry
31
Median 3Y
15.8
Median 5Y
12.7
Industry
13.9
More Details
180.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
180.8
vs History
7
vs Industry
26
Median 3Y
20.9
Median 5Y
20.6
Industry
18
More Details
0.8
EV/IC
EV/IC
Enterprise Value to IC
0.8
vs History
38
vs Industry
68
Median 3Y
0.8
Median 5Y
0.8
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Jointown Pharmaceutical Group Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Jointown Pharmaceutical Group Co Ltd
SSE:600998
24.3B CNY 0.2 11.7 14.2 14.2
US
Mckesson Corp
NYSE:MCK
74.9B USD 0.2 29.7 17.5 20.5
US
Cencora Inc
NYSE:COR
46.5B USD 0.2 30.8 11.3 15.5
US
Amerisourcebergen Corp
LSE:0HF3
46.2B USD 0.2 30.6 11.3 15.4
US
Cardinal Health Inc
NYSE:CAH
29.5B USD 0.1 23.3 10.6 14
US
Henry Schein Inc
NASDAQ:HSIC
8.8B USD 0.7 27.9 12.5 18.5
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW 5.9 89.6 59.9 61.9
CN
Sinopharm Group Co Ltd
HKEX:1099
62.4B HKD 0.1 6.8 1.7 2.1
CN
Huadong Medicine Co Ltd
SZSE:000963
57.1B CNY 1.4 17.8 13.5 13.5
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
56.7B CNY 0.2 14.1 9.1 9.1
IT
Amplifon SpA
MIL:AMP
5.7B EUR 2.4 36.4 11.7 24.3

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 216,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.